INDEPENDENT REPORT REVIEWERS
This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the Institute of Medicine and the National Research Council in making the published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge.
The review comments and draft manuscript remain confidential to protect the integrity of the deliberative process. The National Cancer Policy Board wishes to thank these individuals for their participation in the review of this report.
While the individuals listed below have provided constructive comments and suggestions, it must be emphasized that responsibility for the final content of this report rests entirely with the National Cancer Policy Board, the Institute of Medicine, and the National Research Council.
DILEEP G.BAL, California Department of Health Services, Sacramento
FRANK J.CHALOUPKA, University of Illinois at Chicago
MICHAEL P.ERIKSEN, Centers for Disease Control and Prevention, Atlanta
HAROLD J.FALLON, School of Medicine, University of Alabama at Birmingham
HARVEY J.FINEBERG, Harvard University
STANTON A.GLANTZ, University of California at San Francisco
JACK HENNINGFIELD, Pinney and Associates, Bethesda, Md.
THOMAS P.HOUSTON, American Medical Association, Chicago
MARC MANLEY, Center for Tobacco Reduction and Health Improvement, Blue Cross/Blue Shield of Minnesota, Eagan
MATTHEW MYERS, Campaign for Tobacco-Free Kids, Washington, D.C.
VIRGINIA V.WELDON, Monsanto, Inc., St. Louis, Mo.